CHU Amiens Picardie
Amiens, France
NCT Number: NCT05815134
Endometriosis is a common benign disease in premenopausal women and causes chronic pelvic pain and infertility. This infertility may be due to pelvic adhesions and surgery but also because of poor oocyte quality. It is known that endometriosis is associated with an increase oxidative stress, wich induce chronic inflammation, deleterious effect for DNA, proteins and can caused cellular death. ROS markers found in follicular fluid or in serum are significatively higher in endometriosis women. The investigators want to dose a marker of apoptosis in infertile women and see if it's significatively higher in serum and in follicular fluid of patients with endometriosis compared to others infertility causes and if it's correlated to oocyte quality and IVF results. Real time PCR will be used to dose cell free DNA in serum and follicular fluid of patients undergoing IVF treatment (endometriosis and infertility due to tubal factor, male infertility or idiopathic cause). Then the investigators will compare cell free DNA rate with oocyte and embryo quality and with pregnancy outcomes in the different group.
Looking for future studies?
Notify Me18 year–43 year
Female
Interventional
Not applicable
Amiens, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10ml of blood will be sampled from patients before undergoing IVF treatment, the cell free DNA will be extracted and then quantified by a real time PCR. Another 10ml sample will be drawn the day of oocyte puncture for a new quantification of cell free DNA in plasma and cell free DNA will also be dose in follicular fluid of patients
Time frame: day 1
cell free DNA in serum quantified by real time PCR in patients before they start IVF stimulation
Time frame: day 1
cell free DNA in follicular fluid the day of punction
Time frame: 1 year
number of oocytes reaching the metaphase II in both groups of patients
Time frame: 1 year
fragmentation rate
Time frame: day 2
number of cells at day 2
Time frame: day 3
number of cells at day 3
Time frame: day 5
blastulation rate at day 5 of developement
Time frame: 1 year
Time frame: 1 year
Centre Hospitalier Universitaire, Amiens
Other
Acronym: ENDO-FIV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07471373
Cell Free DNA, Endometrial Microbiota
Salouël, France
View Trial DetailsNCT07241637
Endometriosis, Fatigue
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05962034
Endometriosis, Female Urogenital Diseases
University Park, Pennsylvania, United States
View Trial DetailsNCT05019612
Endometriosis, Expectations
Hamburg, Germany
View Trial Details